Excelera DCE, a Newport Beach-based healthcare AI platform, said it plans to go public through a special purpose acquisition company.
Excelera, which began Jan. 1 this year, said it has entered an agreement with Future Health ESG Corp. and is expected to be listed on the Nasdaq under the new ticker symbol “XLRA.”
“After more than 20 years practicing as a cardiologist, I founded Excelera to deliver a new paradigm of senior care, informed by the latest medical and data science,” Chief Executive Dr. Sanjay Patil said in a statement. “Rather than rationing access to care or avoiding high risk patients, our model actually embraces the opportunity to improve outcomes for the sickest and most vulnerable seniors.”
Excelera, which said its value is around $459 million, is a direct contracting entity, DCE, which has been set up as a relatively new model to control health costs.
